ArticleAntiviral research2020

The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.

Mika Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.